Table 2.
Hazard of waitlisting and deceased-donor transplantation after first KRT (2005–2017) by sex
| Number of Events and Models | Access to Waitlist from Time of First Kidney Failure Treatment | Access to Deceased-Donor Transplantation from Time of First Kidney Failure Treatment |
|---|---|---|
| Outcomes occurring for men, N (% of outcomes occurring in men) | 167,519 (62) | 54,163 (60) |
| Outcomes occurring for women, N (% of outcomes occurring in women) | 103,592 (38) | 35,411 (40) |
| Overall models | Women (versus Men) Hazard Ratio (95% Confidence Interval) | |
| Unadjusted model | 0.80 (0.79 to 0.81) | 0.84 (0.83 to 0.86) |
| Minimally adjusted modela (Model 1) | 0.87 (0.86 to 0.88) | 0.93 (0.91 to 0.94) |
| Fully adjusted modelb (Model 2) | 0.89 (0.89 to 0.90) | 0.94 (0.93 to 0.95) |
a
Adjusted for attributed cause of kidney failure, age, race/ethnicity, and body mass index (BMI).
b
Adjusted for attributed cause of kidney failure, age, race/ethnicity, BMI, yr of first kidney failure treatment, median zip code household income, insurance coverage, Organ Procurement and Transplant Network region, smoking, chronic obstructive pulmonary disease, cancer, coronary artery disease, congestive heart failure, stroke or transient ischemic attack, and peripheral vascular disease.